Zydus Lifesciences signs agreement with Synthon BV for 505(B)(2) oncology product EP News Bureau Feb 12, 2025 Zydus to handle NDA submission and commercialisation in the US; Synthon to lead development and manufacturing
Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market EP News Bureau Jan 19, 2024 Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets, and thereafter, for the manufacturing…
